Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance

Abstract Proton pump inhibitor (PPI)-induced inhibition of dimethylarginine dimethylaminohydrolase 1 (DDAH1), with consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA), might explain the increased cardiovascular risk with PPI use. However, uncertainty exi...

Full description

Saved in:
Bibliographic Details
Main Authors: S. Tommasi, D. J. Elliot, J. A. Hulin, B. C. Lewis, M. McEvoy, A. A. Mangoni
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
R
Q
Online Access:https://doaj.org/article/9e63538099f74fabac8228010a448d65
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items